Carrier-mediated intestinal transport of drugs

被引:323
|
作者
Tsuji, A
Tamai, I
机构
[1] Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa 920
关键词
carrier-mediated transport; transporter; intestinal absorption; amino acid; oligopeptide; glucose; hexose; monocarboxylic acid; lactic acid; short-chain fatty acid; phosphate; bile acid; vitamin; intestinal secretion; active efflux pump; p-glycoprotein; multidrug resistance;
D O I
10.1023/A:1016086003070
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Recent advances in the field of carrier-mediated intestinal absorption of of amino acids, oligopeptides, monosaccharides, monocarboxylic acids, phosphate, bile acids and several water-soluble vitamins across brush-border and basolateral membranes are summarized. An understanding of the molecular and functional characteristics of the intestinal membrane transporters will be helpful in the utilization of these transporters for the enhanced oral delivery of poorly absorbed drugs. Some successful examples of the synthesis of prodrugs recognized by the targeted transporters are described. Functional expression of the multidrug resistance gene product, P-glycoprotein, as a primary active transporter in the intestinal brush-border membrane leads to net secretion of some drugs such as anticancer agents in the blood-to-luminal direction, serving as a secretory detoxifying mechanism and as a part of the absorption barrier in the intestine.
引用
收藏
页码:963 / 977
页数:15
相关论文
共 50 条
  • [31] Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only
    Kell, Douglas B.
    Dobson, Paul D.
    Oliver, Stephen G.
    DRUG DISCOVERY TODAY, 2011, 16 (15-16) : 704 - 714
  • [32] Including carrier-mediated transport in oral uptake prediction of nutrients and pharmaceuticals in humans
    O'Connor, Isabel A.
    Veltman, Karin
    Huijbregts, Mark A. J.
    Ragas, Ad M. J.
    Russel, Frans G. M.
    Hendriks, A. Jan
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2014, 38 (03) : 938 - 947
  • [33] PRESTEADY-STATE KINETICS AND CARRIER-MEDIATED TRANSPORT - A THEORETICAL-ANALYSIS
    WIERZBICKI, W
    BERTELOOT, A
    ROY, G
    JOURNAL OF MEMBRANE BIOLOGY, 1990, 117 (01): : 11 - 27
  • [34] Carrier-mediated transport of monocarboxylic acids in primary cultured epithelial cells from rabbit oral mucosa
    Utoguchi, N
    Watanabe, Y
    Suzuki, T
    Maehara, J
    Matsumoto, Y
    Matsumoto, M
    PHARMACEUTICAL RESEARCH, 1997, 14 (03) : 320 - 324
  • [35] Carrier-Mediated Transport of Monocarboxylic Acids in Primary Cultured Epithelial Cells from Rabbit Oral Mucosa
    Naoki Utoguchi
    Yoshiteru Watanabe
    Takahisa Suzuki
    Junko Maehara
    Yoshiaki Matsumoto
    Mitsuo Matsumoto
    Pharmaceutical Research, 1997, 14 : 320 - 324
  • [36] Is oral absorption of vigabatrin carrier-mediated?
    Nohr, M. K.
    Juul, R. V.
    Thale, Z. I.
    Holm, R.
    Kreilgaard, M.
    Nielsen, C. U.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 69 : 10 - 18
  • [37] Identification and functional expression of a carrier-mediated riboflavin transport system on rabbit corneal epithelium
    Hariharan, Sudharshan
    Janoria, Kumar G.
    Gunda, Sriram
    Zhu, Xiaodong
    Pal, Dhananjay
    Mitra, Ashim K.
    CURRENT EYE RESEARCH, 2006, 31 (10) : 811 - 824
  • [38] Evidence-based approach to assess passive diffusion and carrier-mediated drug transport
    Di, Li
    Artursson, Per
    Avdeef, Alex
    Ecker, Gerhard F.
    Faller, Bernard
    Fischer, Holger
    Houston, J. Brian
    Kansy, Manfred
    Kerns, Edward H.
    Kraemer, Stefanie D.
    Lennernas, Hans
    Sugano, Kiyohiko
    DRUG DISCOVERY TODAY, 2012, 17 (15-16) : 905 - 912
  • [39] Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide
    González, S
    Romero, J
    de Miguel, R
    Lastres-Becker, I
    Villanua, MA
    Makriyannis, A
    Ramos, JA
    Fernández-Ruiz, JJ
    LIFE SCIENCES, 1999, 65 (03) : 327 - 336
  • [40] CARRIER-MEDIATED TRANSPORT OF THE ANTITUMOR AGENT ACIVICIN ACROSS THE BLOOD-BRAIN-BARRIER
    CHIKHALE, EG
    CHIKHALE, PJ
    BORCHARDT, RT
    BIOCHEMICAL PHARMACOLOGY, 1995, 49 (07) : 941 - 945